pyrrolidine has been researched along with Innate Inflammatory Response in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bothiraja, C; Pawar, AP; Rajalakshmi, S; Shinde, MB | 1 |
Brown, GE; Cherepanov, V; Degousee, N; Downey, GP; Gelb, MH; Ghomashchi, F; Glogauer, M; Grinstein, S; Harkin, DW; Kelvin, D; Koh, A; Lindsay, TF; Nallan, L; Plumb, J; Rubin, BB; Sadilek, M; Smart, BP; Stefanski, E; Sun, C; Vachon, E; Yaffe, MB | 1 |
2 other study(ies) available for pyrrolidine and Innate Inflammatory Response
Article | Year |
---|---|
Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVP.
Topics: Animals; Anti-Inflammatory Agents; Desiccation; Diterpenes; Dosage Forms; Drug Stability; Edema; Excipients; Hydrogen Bonding; Inflammation; Polymers; Pyrrolidines; Rats; Rats, Wistar; Solubility | 2009 |
Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activ
Topics: Animals; Arachidonic Acid; Bronchoalveolar Lavage Fluid; CD11b Antigen; Cytosol; Dose-Response Relationship, Drug; Escherichia coli; Group IV Phospholipases A2; Humans; Inflammation; Ionomycin; Leukotriene B4; Mice; Mice, Transgenic; NADPH Oxidases; Neutrophils; Oxygen; Phagocytosis; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pneumonia; Pyrrolidines; Receptors, IgG; Time Factors; Tumor Necrosis Factor-alpha | 2005 |